Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06985602) titled 'Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ' on May 15.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Jiangsu Cancer Institute & Hospital

Condition: Gastroesophageal Adenocarcinoma Gastric Adenocarcinoma

Intervention: Combination Product: Arm 1: Adebrelimab Combined with Chemoradiotherapy Followed by Surgery

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: May 16, 2025

Target Sample Size: 30

Countries of Recruitment: China

To know more, vi...